We are live on ! Find out more
DP

Dearborn Partners Portfolio holdings

AUM $1.85B
1-Year Est. Return 6.59%
This Fund
S&P 500
This Quarter Est. Return
+4.54%
1 Year Est. Return
+6.59%
3 Year Est. Return
+44.33%
5 Year Est. Return
+68.05%
10 Year Est. Return
+241.41%
AUM
$1.15B
AUM Growth
+$77.1M
Cap. Flow
+$32M
Cap. Flow %
2.78%
Top 10 Hldgs %
24.64%
Holding
190
New
8
Increased
98
Reduced
51
Closed
6

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$1.4M
2
CVS icon
CVS Health
CVS
+$1.2M
3
UPS icon
United Parcel Service
UPS
+$1.13M
4
AAPL icon
Apple
AAPL
+$1.05M
5
XLNX
Xilinx Inc
XLNX
+$1.05M

Sector Composition

Rank Sector Weight
1 Healthcare 15.3%
2 Technology 14.52%
3 Industrials 13.42%
4 Consumer Staples 11.59%
5 Consumer Discretionary 6.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ECL icon
76
Ecolab
ECL
$77.6B
$1.96M 0.17%
16,551
+362
+2% +$42.2K
GOOGL icon
77
Alphabet (Google) Class A
GOOGL
$4.26T
$1.84M 0.16%
52,400
BA icon
78
Boeing
BA
$168B
$1.58M 0.14%
12,200
-40
-0.3% -$5.21K
GE icon
79
GE Aerospace
GE
$371B
$1.53M 0.13%
10,119
+3
+0% +$438
VCSH icon
80
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$1.47M 0.13%
18,192
-7,100
-28% -$569K
VOO icon
81
Vanguard S&P 500 ETF
VOO
$972B
$1.45M 0.13%
7,550
-955
-11% -$182K
CRM icon
82
Salesforce
CRM
$149B
$1.43M 0.12%
17,969
ABBV icon
83
AbbVie
ABBV
$445B
$1.38M 0.12%
22,234
-100
-0.4% -$6.09K
IJK icon
84
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.7B
$1.34M 0.12%
31,820
-4,400
-12% -$182K
VONG icon
85
Vanguard Russell 1000 Growth ETF
VONG
$42.4B
$1.31M 0.11%
51,048
-3,600
-7% -$92.1K
SLB icon
86
SLB Ltd
SLB
$72.6B
$1.3M 0.11%
16,386
+681
+4% +$52.2K
AMG icon
87
Affiliated Managers Group
AMG
$9.7B
$1.25M 0.11%
8,903
+311
+4% +$50.9K
SO icon
88
Southern Company
SO
$109B
$1.19M 0.1%
22,154
-775
-3% -$39K
MGK icon
89
Vanguard Morningstar Mega Cap Growth ETF
MGK
$32.1B
$1.15M 0.1%
68,575
-49,355
-42% -$823K
ABT icon
90
Abbott
ABT
$181B
$1.12M 0.1%
28,453
+200
+0.7% +$7.96K
CL icon
91
Colgate-Palmolive
CL
$72.5B
$1.11M 0.1%
15,172
-1,200
-7% -$85.4K
HAR
92
DELISTED
Harman International Industries
HAR
$1.09M 0.09%
15,227
+1,377
+10% +$107K
CSCO icon
93
Cisco
CSCO
$451B
$1.02M 0.09%
35,451
+780
+2% +$21.9K
IDXX icon
94
Idexx Laboratories
IDXX
$43.6B
$1.01M 0.09%
10,900
+500
+5% +$42.9K
PM icon
95
Philip Morris
PM
$299B
$972K 0.08%
9,551
-794
-8% -$79.2K
PFE icon
96
Pfizer
PFE
$142B
$927K 0.08%
27,737
+790
+3% +$25.2K
EMN icon
97
Eastman Chemical
EMN
$7.81B
$909K 0.08%
13,391
-194
-1% -$14.3K
USB icon
98
US Bancorp
USB
$97.7B
$871K 0.08%
21,604
-544
-2% -$22.6K
XLK icon
99
State Street Technology Select Sector SPDR ETF
XLK
$114B
$813K 0.07%
37,474
+7,200
+24% +$156K
PPG icon
100
PPG Industries
PPG
$24.5B
$809K 0.07%
7,770
+600
+8% +$65.5K

Similar funds

Dearborn Partners's Q2 2016 Portfolio in Review

As of Q2 2016, Dearborn Partners held 190 positions worth $1.15B, up 7.2% from $1.08B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Dearborn Partners's Q2 2016 filing shows 8 new, 98 increased, 51 reduced and 6 closed positions. Its largest new stake was Vanguard FTSE Emerging Markets ETF: 15,191 shares worth $535K. The largest sale was Vanguard Morningstar Mega Cap Growth ETF, an estimated $823K.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

  • Dearborn Partners's largest Q2 2016 buy was Vanguard FTSE Emerging Markets ETF: 15,191 shares worth $535K.
  • Dearborn Partners added most to Gilead Sciences in Q2 2016, an estimated $1.4M increase.
  • Dearborn Partners's biggest Q2 2016 reduction was Vanguard Morningstar Mega Cap Growth ETF, cutting an estimated $823K.
  • Dearborn Partners fully exited iShares Currency Hedged MSCI EAFE ETF in Q2 2016, selling an estimated $372K.
  • Dearborn Partners's ten largest holdings make up 25% of its $1.15B portfolio in Q2 2016.
  • Dearborn Partners opened 8 new positions and closed 6 in Q2 2016.
  • Dearborn Partners's portfolio value rose 7.2% quarter-over-quarter to $1.15B.

Based on Dearborn Partners's 13F filing for Q2 2016, filed 18 Jul 2016.